Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

.

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Asim Amin, Elizabeth R. Plimack, Marc S. Ernstoff, Lionel D. Lewis, Todd M. Bauer, David F. McDermott, Michael Carducci, Christian Kollmannsberger, Brian I. Rini, Daniel Y. C. Heng, Jennifer Knox, Martin H. Voss, Jennifer Spratlin, Elmer Berghorn, Lingfeng Yang, Hans J. Hammers
Format: Article
Language:English
Published: BMJ Publishing Group 2019-03-01
Online Access:http://link.springer.com/article/10.1186/s40425-019-0559-3

Internet

http://link.springer.com/article/10.1186/s40425-019-0559-3

Similar Items